3 Indian Growth Stocks Insiders Still Back Heavily

With US core producer prices cooling month over month, inflation pressures look less intense and rate expectations feel less aggressive. Growth stocks can start to matter more when borrowing costs feel less restrictive. That is where fast growing stocks with high insider ownership come in, as management has meaningful skin in the game. This article highlights three stocks from that screener that investors may want on their radar now.

The stocks covered below are just a small sample of this idea, and the full screen surfaced another 105 companies with similarly compelling growth and insider ownership stories that are not in this article. If you want to go straight to the source, use the Fast Growing Stocks With High Insider Ownership screener to identify, filter and analyze the highest conviction opportunities that fit your own criteria.

Rubicon Research (NSEI:RUBICON)

Rubicon Research is a Mumbai based specialty pharmaceutical company that develops complex drug formulations across pain management, cardiovascular, central nervous system and other chronic therapies, and sells a broad mix of generic and specialty pharmaceutical products and related services. The business currently generates about ₹17.54b in revenue from pharmaceutical products, with a heavy skew toward international markets. At a market value of roughly ₹268.01b, Rubicon Research sits firmly in the mid to large cap bracket for Indian pharma stocks.

Rubicon Research stands out on this screener because earnings growth has been strong, with full year 2026 net income of ₹2,467.35m on sales of ₹17,616.83m and improving net margins of 14.1%. Analysts are also expecting earnings and revenue growth to remain faster than the wider Indian market, which helps explain the premium P/E multiple and the current share price that screens above some valuation models. At the same time, investors need to be comfortable with a volatile share price, a funding mix that leans on external borrowing and a valuation that leaves less room for error. If you want growth with meaningful insider ownership, Rubicon Research is a story worth watching more closely.

Rubicon Research’s earnings story and premium P/E can feel like only half the picture. Use the analyst forecasts for Rubicon Research to see how those projections compare with the risks that could quietly shift the narrative.

Build your own high growth and insider backed shortlist

Rubicon Research and the other two stocks in this article all came from a single Simply Wall St screen, but the real value comes from setting your own rules. Use our customisable Screener to mix filters on growth, valuation, quality and risks, or lean on the foundations of our curated Investing Ideas.

Privi Speciality Chemicals (BSE:530117)

Privi Speciality Chemicals is a Mumbai based aroma and fragrance ingredients manufacturer supplying global fragrance houses and FMCG companies across home care, personal care and other everyday products. The business currently generates about ₹26.71b in revenue almost entirely from aromatic chemicals. With a market value of roughly ₹136.08b, Privi Speciality Chemicals sits in the mid to large cap bracket of the Indian chemicals sector.

Privi Speciality Chemicals operates at the intersection of demand for fragrance rich consumer products and a shift toward trusted India based suppliers. The company has undertaken capacity expansions and developed a broader product portfolio aimed at capturing that demand. Earnings, margins and return on equity have been strong in recent years, and the latest quarterly numbers show higher sales, revenue and EPS heading into the July 2026 board review. At the same time, the company carries meaningful debt, the dividend record is patchy and state incentive income is an important support for profitability. Investors therefore need to weigh the quality and durability of current margins. The full picture depends on how those growth plans, customer relationships and incentives hold up through the next investment cycle.

Privi Speciality Chemicals sits at the point where capacity expansion, global FMCG demand and state incentives intersect. However, the real story only comes into focus in the 3 key rewards and 2 important warning signs

Bajel Projects (NSEI:BAJEL)

Bajel Projects is an EPC contractor focused on power transmission and distribution, handling everything from engineering and design through to testing, manufacturing and commissioning of extra high voltage lines and substations in India and overseas. The company currently generates about ₹27.51b in revenue, entirely from its Power Transmission and Power Distribution segment. With a market value around ₹21.79b, Bajel Projects sits in the small to mid cap bracket of the Indian power infrastructure sector.

Investors looking at Bajel Projects are seeing a fast growing EPC player with high quality earnings, strong order wins in India and the Middle East and an outlook that includes forecasts for earnings growth of about 57.7% per year and revenue growth of around 27% per year. That growth comes with trade offs, including a very high P/E multiple, thin net margins of 0.8% and a balance sheet heavily reliant on external borrowings. The dividend is modest at 0.32% and not well covered by free cash flow. The real question is whether the improving profitability, rising forecast ROE and a pipeline of mega and ultra mega transmission orders can justify today’s valuation and funding risk profile.

Bajel Projects appears to be an accelerating growth story, although its thin 0.8% margins and significant borrowing may be masking a potential inflection point. Use the analyst forecasts for Bajel Projects to see how those forecasts could shift the overall picture.

Seeking Alternatives Before The Crowd Moves

Fresh stock stories move fast. Breakout moves, new momentum and under the radar winners often get caught once the crowd arrives. Scan these ideas while it matters and act promptly.

• Spot resilient cash generators before the herd by reviewing the list of solid balance sheet and fundamentals (435 results), which can keep compounding when weaker businesses start dropping.
• Consider potential upside from structural trends by checking the 608 high quality undiscovered gems, which still fly under the radar for now.
• Track income-focused opportunities with staying power using the 438 dividend fortresses, which aim to keep returns flying while others stall.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com